Unternehmensübersicht
Ping An Biomedical Co., Ltd. operates through its subsidiaries to deliver comprehensive supply chain management services specifically within the apparel industry across China, Hong Kong, Cambodia, and Europe. The corporate scope encompasses a wide array of operational functions, including market trend analysis, product design and development, raw material sourcing, production oversight, and quality control. This entity is classified within the Consumer Cyclical sector and functions as part of the Textile Manufacturing industry, positioning it as a player in the manufacturing segment of the broader consumer goods economy. The company's current market capitalization stands at $18.31M, supported by an annual revenue of $34.15M and an operational workforce consisting of 7 employees. These financial metrics indicate a very small market capitalization relative to its reported revenue, suggesting that the company operates on a micro-cap scale with limited public valuation recognition compared to its stated sales volume.
Finanzielle Gesundheit
The financial statements for the trailing twelve months reveal a revenue of $34.15M, a net income of $-12,829,206, and an EBITDA of $-14,695,886. The substantial disparity between the $34.15M in revenue and the negative net income of approximately $12.8 million highlights a severe cost structure issue where operating expenses significantly exceed gross profits, resulting in an overall loss. The company reports a free cash flow of $-59,241,688, which indicates a heavy cash burn rate that severely restricts financial flexibility and the ability to fund operations without external financing. Analysis of the profitability margins shows a gross margin of 2.8%, an operating margin of -69.6%, and a profit margin of -37.6%. The negative operating margin of -69.6% reveals that core business operations are generating losses that are not covered by gross revenue, while the negative profit margin confirms that the bottom line is deeply compromised by these operational inefficiencies. On the balance sheet, the company holds $1.17M in cash against $10.47M in debt, resulting in a debt-to-equity ratio of 23.14, which characterizes a highly leveraged and risky financial position rather than a conservative one. Despite the high leverage, the current ratio is 2.76, suggesting that the company theoretically possesses sufficient current assets to cover its short-term liabilities, though this liquidity buffer is likely eroded by the continuous cash outflows. Furthermore, the return on equity is -67.4% and the return on assets is -14.7%, metrics that collectively demonstrate a complete lack of management effectiveness in generating value for shareholders or utilizing assets productively.
Bewertungsanalyse
Valuation multiples for the trailing twelve months and forward periods are both listed as N/A, implying that traditional earnings-based valuation methods are currently inapplicable due to the absence of positive earnings. The absence of a forward P/E suggests that the market is not pricing in a near-term recovery of earnings to generate a positive multiple. The price-to-book ratio is recorded at 0.46, indicating that the market values the company at less than half of its book value, which often signals deep value characteristics or significant concerns regarding asset quality and future earnings potential. The price-to-sales ratio stands at 0.54, while the EV/EBITDA is -0.88; these alternative metrics suggest a valuation based on sales rather than earnings, reflecting the market's reliance on revenue stability in the absence of profitability. The stock has experienced extreme volatility over the past year, with a 52-week high of $5.40 and a 52-week low of $0.12. Relative to this wide trading range, the current price sits significantly closer to the 52-week low, reflecting a prolonged period of depreciation and investor skepticism regarding the company's fundamentals. The beta is listed as N/A, which prevents a direct comparison of price volatility relative to the broader market index, leaving the specific risk profile regarding market movements undefined by this metric.
Growth & Income
The revenue growth year-over-year is -62.0%, while earnings growth is N/A due to the negative earnings base. The contraction in revenue of 62.0% indicates a shrinking business footprint or a loss of significant market share within the apparel supply chain sector. Since earnings are negative, a direct comparison of growth rates between earnings and revenue is not mathematically feasible, but the simultaneous decline in revenue suggests a fundamental deterioration in the company's core business model rather than a cyclical fluctuation. The dividend yield is N/A and the payout ratio is 0.0%, confirming that the company does not distribute any dividends to shareholders. Consequently, the company reinvests its limited earnings, if any, or relies on equity issuance to fund operations, as it lacks the retained earnings necessary to support a dividend policy. This non-dividend status aligns with the company's negative cash flow and inability to generate sustainable profits. The overall growth and income profile is characterized by significant revenue contraction, negative profitability, and a complete absence of income distribution to investors.